Tramadol Hydrochloride
Product Images NDC 45865-115

4 FDA label images from Medsource Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 45865-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Tramadol HCl Tablets 50 mg (Pdp 115)

Tramadol HCl Tablets 50 mg (Pdp 115)
Tramadol HCl Tablets 50 mg packaging label from Medsource Pharmaceuticals. The label indicates these are generic for Ultram and include dosage instructions to take one tablet every specified hours as needed for pain. The product NDC 45865-0115-60 is displayed along with warnings about possible dizziness or drowsiness and avoiding alcohol.*
FDA Label Image

Structure (Tramadol 1)

Structure (Tramadol 1)
Chemical structure diagram of tramadol hydrochloride showing its molecular framework with labeled bonds and groups, including the hydrochloride (HCl) component.*
FDA Label Image

Figure 1 (Tramadol 2)

Figure 1 (Tramadol 2)
A pharmacokinetic curve depicting the concentration (ng/mL) of tramadol hydrochloride and its metabolite M1 over time (hours) after single and multiple doses. The graph shows concentration profiles for tramadol and M1 with distinct lines and markers, illustrating drug and metabolite levels up to 48 hours post-dose.*
FDA Label Image

Figure 2 (Tramadol 3)

Figure 2 (Tramadol 3)
A line graph titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting,' showing percent discontinuing on the vertical axis and days in double-blind on the horizontal axis for a 10-day period at 200 mg/day dosage. The graph depicts a progressive increase in discontinuation over 25 days.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.